Lifetime Prevalence and Factors Associated with @entity542 among Older XXXX in Low and Middle Income Countries: A 10/66 Study.

@entity1 @entity131 @entity303 @entity542 @entity909
INTRODUCTION: @entity131 ( @entity131 ) is a growing public health problem around the world, yet there is little information on the prevalence of @entity542 in low and middle income countries (LMICs). We utilised data collected by the 10/66 research group to investigate the lifetime prevalence of @entity542 in defined sites in low and middle income countries, its risk factors and its relationship with disability. METHODS: We analysed data from one-phase cross-sectional surveys of all residents aged 65 years and older (n = 16430) distributed across twelve sites in eight low and middle income countries (China, Cuba, Dominican Republic, India, Venezuela, Mexico, Peru, and Puerto Rico). Self-reported cases of @entity542 with @entity909 were identified during the interview. A sensitivity analysis including data provided by informants of @entity1 with @entity303 was also used to estimate the impact of this information on the estimates. Prevalence ratios (PR) from Poisson regressions were used to identify associated risk factors. RESULTS: The standardised lifetime prevalence of @entity131 ranged from 0.3% in China to 14.6% in rural Mexico and Venezuela. Being male (PR: 1.6, 95% CI: 1.29-1.82), younger (PR: 0.95, 95% CI: 0.92-0.99), with lower education (PR 0.91, 95% CI: 0.86-0.96), and having fewer assets (PR 0.92, 95% CI: 0.88-0.96), was associated with a higher prevalence of @entity131 when pooling estimates across sites. DISCUSSION: Our analysis revealed that the prevalence of @entity131 in LMICs is similar to that of developed nations. Considering the growing impact of @entity131 on health resources in these countries, there is an urgent need for further research.
